Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
Psychiatrist and sex therapist, Madeleine M. Castellanos, MD, explains how thoughts and feelings can manifest themselves as physical symptoms in our bodies. Dr. Castellanos references an interesting study…
Rebecca Kaltman, MD, oncologist and founder of Breast Cancer Consultants, explains why telemedicine is increasingly being embraced by both patients and specialist practitioners. In terms of cancer treatment,…
Each week, The Doctor's Channel and IMS Health's Appscript.net present you with a useful and thoughtfully designed app that can help both patients and their physicians with health-related…
Yelena Havryliuk, MD, FACOG, Assistant Professor of Obstetrics and Gynecology at Weill Cornell Medical College, describes why the Acessa treatment for uterine fibroids might be better than other…
When a fetus is exposed to high blood glucose because of maternal diabetes, this can have long-lasting effects on development. A new study examined whether exposure to maternal…
Each year, more than one and a half million women in the United States undergo a breast biopsy. After a breast biopsy, a pathologist evaluates the tissue to…
Wearable technology is in the spotlight lately with the coming of the Apple Watch and the proliferation of fitness trackers and the internet of things (IoT). With all…
Yelena Havryliuk, MD, FACOG Uterine fibroids are benign tumors that form on the muscle walls of the uterus. These fibroids are estimated to occur in 50-70% of females…
Yelena Havryliuk, MD, FACOG, Assistant Professor of Obstetrics and Gynecology, Weill Cornell Medical College, discusses the top three options for fibroid management. The first treatment option is hormonal…
